The following information was reported to gore: on (b)(6) 2019 a patient was undergoing treatment of a right distal popliteal lesion with a gore® viabahn® endoprosthesis with propaten bioactive surface.The lesion was predilated by means of angioplasty.The device was advanced to the target location and positioned.The deployment knob was unscrewed and the deployment line was pulled.The endoprosthesis started to deploy a few millimeters, however resistance was felt, so pulling on the line was stopped.This device was removed from the patient through the sheath.
|
H.6.Results code 2: 213: the engineering evaluation stated the following: the entire device was returned.There was approximately 31.5cm of deployment line between the hub and deployment knob.Approximately 2.5cm of the distal shaft, upon which the endoprosthesis is mounted, was exposed at the transition.Approximately 1.5cm of the endoprosthesis was expanded.The remainder of the endoprosthesis was constrained by the inner braided constraining line.The endoprosthesis was longitudinally compressed towards the tip end of the device with the expanded portion of the endoprosthesis covering the distal tip.The endoprosthesis appeared to be damaged with outwardly flared struts throughout the expanded portion.Additionally, the wire stent appeared to be delaminating from the graft.The rest of the device appeared unremarkable.Deployment was able to be continued with traction on the deployment line at the endoprosthesis.Engineering evaluation conclusion is inconclusive as it relates to the event description.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
|